In development: Guidance, quality standards and advice

Skip to filters Skip to results

Showing 76 to 100 of 388

Sort by

Guidance, NICE advice and quality standards in development
Title	Type	Expected publication date
Dasatinib for treating Philadelphia-chromosome-positive acute lymphoblastic leukaemia in children and adults [ID1297]	Technology appraisal guidance	28 July 2021
Datopotamab deruxtecan for previously treated hormone receptor-positive HER2-negative unresectable or metastatic breast cancer [ID6348]	Technology appraisal guidance	TBC
DCVax-L for treating glioblastoma [ID836]	Technology appraisal guidance	TBC
Decitabine–cedazuridine with venetoclax for untreated acute myeloid leukaemia when intensive induction chemotherapy is unsuitable [ID6601]	Technology appraisal guidance	24 March 2027
Degarelix before or with radiotherapy for treating high-risk localised and locally advanced hormone-dependent prostate cancer [ID6419]	Technology appraisal guidance	TBC
Denecimig (Mim8) for preventing bleeding episodes in haemophilia A in people of any age [ID6400]	Technology appraisal guidance	24 February 2027
Depemokimab for treating severe eosinophilic asthma in people 12 years and over [ID6447]	Technology appraisal guidance	TBC
Deuruxolitinib for treating severe alopecia areata [ID6597]	Technology appraisal guidance	8 October 2026
Deutetrabenazine for treating tardive dyskinesia [ID6550]	Technology appraisal guidance	TBC
Dexmedetomidine for treating agitation associated with bipolar disorder in people 18 to 75 years [TSID10725]	Technology appraisal guidance	TBC
Dexmedetomidine for treating agitation associated with schizophrenia [TSID10726]	Technology appraisal guidance	TBC
Diabetes in pregnancy: management from preconception to the postnatal period - Managing type 1 diabetes (T1D) using hybrid closed loops (update)	NICE guideline	12 August 2026
Digital platforms to support rehabilitation before and after primary elective hip or knee replacement surgery	Health technology evaluation	11 August 2026
Digital technologies delivering CBT for insomnia in adults	Health technology evaluation	6 January 2027
Digital technologies for applying algorithms to spirometry to support asthma and COPD diagnosis in primary care and community diagnostic centres: early-use assessment	Health technology evaluation	2 April 2026
Digital technologies for multidisciplinary weight management	Health technology evaluation	TBC
Digital technologies for the early detection and initial diagnosis of adult hearing loss (provisional title)	HealthTech guidance	TBC
Digital technologies to support monitoring of vision change at home for people with age-related macular degeneration: early use assessment	Health technology evaluation	15 September 2026
Digital technologies to support self-management of asthma: early value assessment	Health technology evaluation	30 April 2026
Digital technologies to support smoking cessation in secondary care patients: early value assessment	Health technology evaluation	TBC
Domestic Abuse	NICE guideline	8 October 2027
Domvanalimab with zimberelimab for untreated unresectable advanced gastric, gastro-oesophageal junction or oesophageal cancer [ID6606]	Technology appraisal guidance	TBC
Donanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID6222]	Technology appraisal guidance	TBC
Donidalorsen for preventing recurrent attacks of hereditary angioedema in people 12 years and over [ID6457]	Technology appraisal guidance	18 June 2026
Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency (MA review of TA779) [ID6326]	Technology appraisal guidance	23 July 2026

Results per page

10
25
50
All